Paul Chang

Paul Chang is an Analyst at Sofinnova Investments (BioEquities), based in San Francisco, CA, where he focuses on public investments in medical technology and diagnostics. In his current role, he is responsible for identifying high-growth opportunities across medical device, diagnostic, and related healthcare sectors within public equity markets.

Previously, Paul worked as an Investment Associate at TPG Growth, concentrating on healthcare investments and providing operational support to portfolio companies. Prior to TPG, he was an Investment Banking Analyst at Goldman Sachs, specializing in healthcare M&A and financing transactions.

Paul holds a BS in Finance with a minor in English Literature from New York University (NYU Stern). He has demonstrated expertise in evaluating growth-stage and public market healthcare companies, with a proven track record in sourcing, due diligence, and portfolio management within medical technology and diagnostics.